A detailed history of Farther Finance Advisors, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 161 shares of GKOS stock, worth $22,288. This represents 0.0% of its overall portfolio holdings.

Number of Shares
161
Previous 190 15.26%
Holding current value
$22,288
Previous $22.3 Million 5.98%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$113.62 - $135.39 $3,294 - $3,926
-29 Reduced 15.26%
161 $21 Million
Q2 2024

Jul 31, 2024

BUY
$89.48 - $118.35 $4,921 - $6,509
55 Added 40.74%
190 $22.3 Million
Q1 2024

May 13, 2024

BUY
$76.4 - $96.33 $1,451 - $1,830
19 Added 16.38%
135 $12.6 Million
Q4 2023

Feb 14, 2024

BUY
$59.53 - $85.11 $6,905 - $9,872
116 New
116 $9.22 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.59B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.